MDS AND AML PRIOR TO ALLOGENEIC SCT

Clinical trials for MDS AND AML PRIOR TO ALLOGENEIC SCT explained in plain language.

Never miss a new study

Get alerted when new MDS AND AML PRIOR TO ALLOGENEIC SCT trials appear

Sign up with your email to follow new studies for MDS AND AML PRIOR TO ALLOGENEIC SCT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Precision proton beam may boost transplant safety for tough blood cancers

Disease control Recruiting now

This study tests a new way to prepare patients with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) for a stem cell transplant. Instead of standard radiation, they receive targeted proton radiation to the bone marrow, aiming to reduce side effects. About …

Matched conditions: MDS AND AML PRIOR TO ALLOGENEIC SCT

Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control

Last updated May 13, 2026 15:58 UTC

MDS AND AML PRIOR TO ALLOGENEIC SCT

Get alerted when new MDS AND AML PRIOR TO ALLOGENEIC SCT trials appear

Precision proton beam may boost transplant safety for tough blood cancers